Medbroadcast  Powered by MediResource
 Search

Go
 Browse alphabetically
ABCDEFGHIJKLMN
OPQRSTUVWXYZ
HEALTH TOPICS
Family & Child Health
Men's Health
Women's Health
Seniors' Health
Addiction
Allergy
Ankylosing Spondylitis
Arthritis (Rheumatoid)
Asthma
Atrial Fibrillation
Baby Health
Back Health
Bedwetting
Bladder (Overactive)
Brain Health
Cancer
Childhood Vaccinations
Cholesterol
Crohn's & Colitis
Cold and Flu
COPD NEW!
Cosmetic Procedures
Depression NEW!
Diabetes
Digestive Health
Ear Health
Eating Disorders
Eye Health
Flu (Seasonal)
Fertility
Fitness
Healthy Skin
Heart
High Blood Pressure
HPV
Hyperhidrosis
Incontinence
Infection
Kidney Health
Lung Health
Medications and your Health
Menopause
Mental Health
Multiple Sclerosis NEW!
Natural and Complementary Therapy
Nutrition
Obesity
Oral Care
Osteoarthritis of the Knee NEW!
Pain
Pregnancy
Psoriasis
Psoriatic Arthritis (PsA)
Seasonal Health
Sexual Health
Sleep Health
Stroke Risk Reduction
Smoking
Weight Management
Workplace Health
Yeast Infection
All health channels

STAY CONNECTED
RESOURCES
Ask an Expert
Clinical Trials
Find a Specialist
Health features
News
Tools


Condition Info Drug Info Tests and Procedures Natural Products Ask an Expert Support Groups Clinical Trials
Home Bookmark Page Send to a Friend Sante Chez Nous Subscribe
Drug Info > J > Jurnista
Please enter the drug name or
DIN (Drug Identification Number)


GoGO

Search by first letter

ABCDEFGHIJKLMNOPQRSTUVWXYZ

Brand Name

Jurnista

Common Name
hydromorphone controlled-release


In this drug factsheet:



DIN (Drug Identification Number)

02337266 JURNISTA 4MG EXTENDED-RELEASE TABLET
02337274 JURNISTA 8MG EXTENDED-RELEASE TABLET
02337282 JURNISTA 16MG EXTENDED-RELEASE TABLET
02337290 JURNISTA 32MG EXTENDED-RELEASE TABLET

How does this medication work? What will it do for me?

Hydromorphone controlled-release belongs to the family of medications known as opioid analgesics (narcotic pain relievers). It is used to treat chronic, severe pain. Hydromorphone works on the brain to increase the ability to tolerate pain. Hydromorphone controlled-release works by gradually releasing the medication into the body to help control pain that requires the prolonged or continuous use of an opioid pain killer.

This medication may be available under multiple brand names and/or in several different forms. Any specific brand name of this medication may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of this medication may not be used for all of the conditions discussed here.

Your doctor may have suggested this medication for conditions other than those listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are taking this medication, speak to your doctor. Do not stop taking this medication without consulting your doctor.

Do not give this medication to anyone else, even if they have the same symptoms as you do. It can be harmful for people to take this medication if their doctor has not prescribed it.

How should I use this medication?

[Jurnista]

For people who are not currently taking other opioid pain medications or are taking low doses of weak opioid medications, the usual adult dose of hydromorphone controlled-release tablets is 4 mg every 24 hours.

For people who are receiving other formulations of hydromorphone or other opioid medications, the dose depends on the dose of these medications that you are currently taking. Your doctor will determine the dose that is appropriate for you.

Your doctor can adjust your dose every 48 hours until a dose that controls your pain with tolerable side effects is reached.

Your daily dose should be taken once every 24 hours. Swallow hydromorphone controlled-release tablets whole. Do not chew, crush, dissolve, or break the contents of the tablet, as this could result in too much hydromorphone being released rapidly and could be fatal.

You may notice what appears to be a tablet in your stool. This is normal and occurs because the tablet does not completely dissolve after all the medication has been released in the body.

It is important that this medication be taken exactly as prescribed by your doctor. If you miss a dose, take it as soon as possible and continue with your regular schedule. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. If you are not sure what to do after missing a dose, contact your doctor or pharmacist for advice.

Store this medication at room temperature and keep it out of the reach of children.

Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.





What form(s) does this medication come in?

Jurnista

4 mg
Each pale beige, round, biconvex, prolonged-release tablet, with "HM 4" printed in black ink on one side, contains 4.36 mg and delivers 4 mg hydromorphone HCl, equivalent to 3.56 mg hydromorphone base. Nonmedicinal ingredients: butyl hydroxytoluene, cellulose acetate, ferric oxide red, ferric oxide yellow, hypromellose, iron oxide black, lactose anhydrous, macrogol, magnesium stearate, polyethylene oxide, povidone, propylene glycol, sodium chloride, and titanium dioxide. May contain traces of sodium metabisulfite.

8 mg
Each red, round, biconvex, prolonged-release tablet, with "HM 8" printed in black ink on one side, contains 8.72 mg and delivers 8 mg hydromorphone HCl, equivalent to 7.12 mg hydromorphone base. Nonmedicinal ingredients: butyl hydroxytoluene, cellulose acetate, ferric oxide red, glycerol triacetate, hypromellose, iron oxide black, lactose anhydrous, lactose monohydrate, macrogol, magnesium stearate, polyethylene oxide, povidone, propylene glycol, sodium chloride, and titanium dioxide. May contain traces of sodium metabisulfite.

16 mg
Each yellow, round, biconvex, prolonged-release tablet, with "HM 16" printed in black ink on one side, contains 16.35 mg and delivers 16 mg hydromorphone HCl, equivalent to 14.24 mg of hydromorphone base. Nonmedicinal ingredients: butyl hydroxytoluene, cellulose acetate, ferric oxide yellow, glycerol triacetate, hypromellose, iron oxide black, lactose anhydrous, lactose monohydrate, macrogol, magnesium stearate, polyethylene oxide, povidone, propylene glycol, sodium chloride, and titanium dioxide. May contain traces of sodium metabisulfite.

32 mg
Each white, round, biconvex, prolonged-release tablet, with "HM 32" printed in black ink on one side, contains and delivers 32.00 mg hydromorphone HCl, equivalent to 28.48 mg of hydromorphone base. Nonmedicinal ingredients: butyl hydroxytoluene, cellulose acetate, ferric oxide yellow, glycerol triacetate, hypromellose, iron oxide black, lactose anhydrous, lactose monohydrate, macrogol, magnesium stearate, polyethylene oxide, povidone, propylene glycol, sodium chloride, and titanium dioxide. May contain traces of sodium metabisulfite.

Who should NOT take this medication?

Do not take this medication if you:

  • are allergic to hydromorphone, other opioid (narcotic) pain medications (e.g., morphine, codeine, oxycodone) or to any of the ingredients of the medication
  • are taking or have taken (within the last 14 days) MAO inhibitors (e.g., phenelzine, tranylcypromine)
  • have had surgery or have an underlying condition that may cause narrowing or obstruction of the intestines
  • have acute alcoholism
  • have acute asthma or other obstructive lung disease
  • have acute pain, or pain following surgery
  • have acute respiratory depression (slowed breathing)
  • have a head injury
  • have convulsions or seizure disorders
  • have cor pulmonale (heart failure caused by chronic high blood pressure in the arteries of the lungs)
  • have delirium tremens (e.g., confusion, diarrhea, shaking, fever, hallucinations, disorientation) associated with alcohol withdrawal
  • have increased carbon dioxide levels in the blood
  • have increased intracranial pressure (increased pressure inside the head), cerebrospinal pressure, or head injury
  • have mild or intermittent pain that can otherwise be managed
  • have pulmonary edema (fluid build-up in the lungs)
  • have severe central nervous system (CNS) depression (slowed nervous system)
  • have or may have surgical abdomen (e.g., paralytic ileus)
  • are pregnant, in labour or delivering, or breastfeeding


 

Advertisement


Did you find what you were looking for on our website? Please let us know.


 Search for information related to
GO
ABCDEFGHIJKLMNOPQRSTUVWXYZ
 

Hot Topics - Bedwetting, Depression, Flu (Seasonal), Healthy Skin, Incontinence, Multiple Sclerosis, Psoriasis, Stroke Risk Reduction

Condition and disease information is written and reviewed by the MedBroadcast Clinical Team.


The contents of this site are for informational purposes only and are meant to be discussed with your physician or other qualified health care professional before being acted on. Never disregard any advice given to you by your doctor or other qualified health care professional. Always seek the advice of a physician or other licensed health care professional regarding any questions you have about your medical condition(s) and treatment(s). This site is not a substitute for medical advice.
© 1996 - 2014 MediResource Inc. - MediResource reaches millions of Canadians each year.